Orexo: Zubsolv Rx data
Research Update
2017-11-28
09:35
The market share (rolling 4 weeks average) for Zubsolv tablets reached 5.17%, as of the 17th of November. The market share based on the number of prescriptions was at 4.99%. On a monthly basis, the overall market for buprenorphine/naloxone based opioid addiction treatments showed a y/y growth rate of 8.9% (TRx) and 9.7% (quantity), as of the 17th of November.
KP
Klas Palin
Disclosures and disclaimers